Teplizumab’s immunomodulatory effects on pancreatic β-cell function in type 1 diabetes mellitus

Teplizumab’s immunomodulatory effects on pancreatic β-cell function in type 1 diabetes mellitus

Abstract This review explores the immunomodulatory potential of Teplizumab and its impact on pancreatic β-cell function in T1D. Characterized by the autoimmune destruction of insulin-producing beta cells, T1D’s management involves maintaining glycemic control through exogenous insulin. Teplizumab, a...

Full description

Bibliographic Details
Main Authors: Emmanuel Kokori, Gbolahan Olatunji, Ikponmwosa Jude Ogieuhi, John Ehi Aboje, Doyin Olatunji, Sikiru Ademola Aremu, Stephen Chukwuemeka Igwe, Abdulrahmon Moradeyo, Yusuf Ismaila Ajayi, Nicholas Aderinto
Format: Article
Language:English
Published: BMC 2024-08-01
Series:Clinical Diabetes and Endocrinology
Subjects:
Teplizumab
Type 1 diabetes memploys a narrative approachellitus
Pancreatic β-cells
Immunomodulation
CD3 antigen
Online Access:https://doi.org/10.1186/s40842-024-00181-w

Internet

https://doi.org/10.1186/s40842-024-00181-w

Similar Items